Ultimately, six CARMRs (ALYREF, DNMT1, DNMT3B, EXO1, HNRNPA2B1, TRDMT1) were included in our analysis to establish a prognostic model for estimating the risk of PCa recurrence. The gene discussed is DNMT3B; the disease is posterior cortical atrophy.